ARTICLE | Company News
Amgen, Transkaryotic, Aventis Pharmaceuticals Inc. renal, hematology news
April 24, 2000 7:00 AM UTC
A trial date of May 15 has been set for AMGN's erythropoietin patent infringement suit against TKTX and TKTX partner Aventis in the U.S. District Court for the District of Massachusetts (see BioCentur...